Study of Dhatripanaka In The Management Of Garbhini Chardi (Emesis Gravidarum):A Comparative Study

Clinical Evaluation Of Dhatripanaka In The Management Of Garbhini Chardi Emesis Gravidarum A Comparative Study - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075395

Enrollment

Registered

2024-10-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O219- Vomiting of pregnancy, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: -patients having confirmed diagnosis of pregnancy. -pregnant women of both primi and multigravida. -pregnant women having classical features of Garbhini Chardi. -first trimester pregnant lady .

Exclusion criteria

Exclusion criteria: -patient with Hyperemesis gravidarum. -patient with molar pregnancy,complicated pregnancy and high risk cases - vomiting due to other medical and surgical problems.

Design outcomes

Primary

Measure	Time frame
Decrease in the symptoms like 1. Chardi - number of vegas will decrease 2.Hrillasa- decrease of nausea 3.Aruchi-decrease of loss of appetiteTimepoint: 7days	—

Secondary

Measure	Time frame
Complete cessation of vomiting & other associated symptoms like - 1.asya samsravan(excessive salivation) 2.shrama(fatigue) 3.Tandra(drowsiness) 4.improve in general healthTimepoint: 21days	—

Countries

India

Contacts

Public ContactDr Kaushalya Khakhlary

Govt. Ayurvedic College & Hospital,Jalukbari,Guwahati,Assam,781014

drkaushalya01@gmail.com8638787369

Outcome results